Related Experiment Video
Updated: Jul 11, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.0K
Reproducibility of pulmonary function tests in patients with systemic sclerosis.
P Jacquerie1, B André2, D De Seny3
1Rheumatology Department, CHU LiègeULiège, Domaine Universitaire Sart Tilman, B35, 4020, Liège, Belgium. pjacquerie@chuliege.be.
Scientific Reports
|November 4, 2023
Summary
Pulmonary function tests (PFTs) are reproducible over 30 days in systemic sclerosis (SSc) patients, regardless of interstitial lung disease (ILD) presence. These findings support PFTs
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Autoimmune Diseases
Background:
- Systemic sclerosis (SSc) is a rare autoimmune disease where interstitial lung disease (ILD) significantly increases morbidity and mortality.
- Clinical management of SSc-ILD relies heavily on pulmonary function testing (PFTs) and tracking changes over time.
- Limited data exists on the reproducibility of PFTs in SSc patients, crucial for reliable disease monitoring.
Purpose of the Study:
- To assess the test-retest reliability and 30-day reproducibility of PFTs in SSc patients.
- To determine potential physiologic variations in PFT parameters over time.
- To compare PFT reproducibility between SSc patients with and without ILD.
Main Methods:
- Prospective observational study involving 25 SSc patients (14 with ILD, 11 without).
- PFT parameters (FVC, FEV1/FVC ratio, DLCO, KCO) measured at four timepoints: T0, 3 hours (H3), 15 days (D15), and 30 days (D30).
- Statistical analysis included mixed linear models and Bland-Altman tests to evaluate reproducibility and time/group effects.
Main Results:
- No significant influence of time or group (ILD vs. non-ILD) on FVC, FEV1/FVC ratio, or DLCO measurements.
- PFT parameters demonstrated reproducibility over the 30-day study period.
- Bland-Altman analysis confirmed reproducibility for FVC and DLCO in both groups.
Conclusions:
- Pulmonary function tests are reproducible over time in clinically stable SSc patients.
- No significant differences in PFT reproducibility were observed between SSc patients with and without ILD.
- These findings support the continued use of PFTs in the clinical management of SSc patients.
More Related Videos
Related Concept Videos
Pulmonary Function Tests
345
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
345
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K

